What does Protealis do?

Protealis is a research organisation in Gent. Public Limited, started on 16 March 2021, 2 establishments.

What is the address of Protealis?

The registered office of Protealis is located at Technologiepark-Zwijnaarde 94, 9052 Gent.

Is Protealis still active?

Yes. According to the CBE (29 October 2026) Protealis is active, legal situation “Normale toestand”, started on 16 March 2021.

Is Protealis registered on Peppol?

Yes, Protealis is registered on the Peppol network with ID 0208:0765251410.

What is the enterprise number of Protealis?

The enterprise number of Protealis is BE0765251410.

When was Protealis founded?

Protealis was founded on 16 March 2021.

Who are the directors of Protealis?

According to the 2025 annual accounts, the directors of Protealis are: DE LIER, Tom VIAENE, Willem BROEKAERT, KORYS MANAGEMENT, Johan CARDOEN, Hartmut VAN LENGERICH, Innovation Industries Fund II Coöperatief U.A., Patrik HAESEN.

Is Protealis a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 March 2021; 4 annual accounts filed, latest fiscal year 2025; 10 directors known from the annual account; 2 establishments in the CBE.

How much profit did Protealis make in 2025?

Protealis recorded a loss after taxes of € 4,979,529 in financial year 2025.

What is the revenue of Protealis?

As a small company, Protealis is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,080,963.

How much does an employee at Protealis earn?

The average wage cost per full-time employee at Protealis was € 120,800 in 2025: staff costs of € 2.1 million for 17.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Protealis have?

According to the 2025 annual accounts, Protealis has 17.2 full-time equivalents (FTE).

Protealis (Public Limited) - Gent - BE0765251410

Dossier Protealis, printed on 29 October 2026 from databakkes.be/en/0765251410/protealis. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

Protealis from Gent, company number BE0765251410, closed financial year 2025 with a result of € -5 million after tax. For that financial year Protealis recorded a gross margin of € 1.1 million and equity of € 9.1 million. Compared with financial year 2024, the result moved from € -3.8 million to € -5 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 5, 2026.

What it is worth Healthy

€ 9.1 million

▼ 35% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -5 million

▼ 30 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.3 million

▲ 87% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -8.8 million.

People and assets in 2025

Full-time equivalents

17.2

▲ 2.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 2.1 million

▲ 27% vs 2024

€ 120,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 61,535

▲ 31% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 600,821

▲ 45% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 320,378

▲ 12% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 421,973 Gross margin 2022: € 421,973 First fiscal year in the series	€ 860,280 Gross margin 2023: € 860,280 ▲ 104% vs 2022 (€ 421,973) Favourable step	€ 1,030,887 Gross margin 2024: € 1,030,887 ▲ 20% vs 2023 (€ 860,280) Favourable step	€ 1,080,963 Gross margin 2025: € 1,080,963 ▲ 5% vs 2024 (€ 1,030,887) Favourable step	▲ 5%
Profit after taxes	€ -3,897,840 Profit after taxes 2022: € -3,897,840 First fiscal year in the series	€ -3,298,751 Profit after taxes 2023: € -3,298,751 ▲ € 599,090 vs 2022 (€ -3,897,840) Favourable step	€ -3,841,671 Profit after taxes 2024: € -3,841,671 ▼ € 542,920 vs 2023 (€ -3,298,751) Unfavourable step	€ -4,979,529 Profit after taxes 2025: € -4,979,529 ▼ € 1.1 million vs 2024 (€ -3,841,671) Unfavourable step	▼ € 1.1 million
Equity	€ 6,142,960 Equity 2022: € 6,142,960 First fiscal year in the series	€ 6,883,409 Equity 2023: € 6,883,409 ▲ 12% vs 2022 (€ 6,142,960) Favourable step	€ 14,041,746 Equity 2024: € 14,041,746 ▲ 104% vs 2023 (€ 6,883,409) Favourable step	€ 9,062,218 Equity 2025: € 9,062,218 ▼ 35% vs 2024 (€ 14,041,746) Unfavourable step	▼ 35%
Total debts	€ 1,911,630 Total debts 2022: € 1,911,630 First fiscal year in the series	€ 1,406,579 Total debts 2023: € 1,406,579 ▼ 26% vs 2022 (€ 1,911,630) Favourable step	€ 2,135,678 Total debts 2024: € 2,135,678 ▲ 52% vs 2023 (€ 1,406,579) Unfavourable step	€ 2,057,662 Total debts 2025: € 2,057,662 ▼ 4% vs 2024 (€ 2,135,678) Favourable step	▼ 4%
Cash	€ 4,461,570 Cash 2022: € 4,461,570 First fiscal year in the series	€ 4,970,861 Cash 2023: € 4,970,861 ▲ 11% vs 2022 (€ 4,461,570) Favourable step	€ 668,845 Cash 2024: € 668,845 ▼ 87% vs 2023 (€ 4,970,861) Unfavourable step	€ 1,251,036 Cash 2025: € 1,251,036 ▲ 87% vs 2024 (€ 668,845) Favourable step	▲ 87%
Retained profit	€ -3,897,840 Retained profit 2022: € -3,897,840 First fiscal year in the series	€ -7,196,591 Retained profit 2023: € -7,196,591 ▼ € 3.3 million vs 2022 (€ -3,897,840) Unfavourable step	€ -3,841,671 Retained profit 2024: € -3,841,671 ▲ € 3.4 million vs 2023 (€ -7,196,591) Favourable step	€ -8,821,200 Retained profit 2025: € -8,821,200 ▼ € 5 million vs 2024 (€ -3,841,671) Unfavourable step	▼ € 5 million
Balance sheet total	€ 8,054,590 Balance sheet total 2022: € 8,054,590 First fiscal year in the series	€ 8,289,988 Balance sheet total 2023: € 8,289,988 ▲ 3% vs 2022 (€ 8,054,590) Unchanged	€ 16,177,424 Balance sheet total 2024: € 16,177,424 ▲ 95% vs 2023 (€ 8,289,988) Unchanged	€ 11,119,880 Balance sheet total 2025: € 11,119,880 ▼ 31% vs 2024 (€ 16,177,424) Unchanged	▼ 31%
Employees (FTE)	6.1 Employees (FTE) 2022: 6.1 First fiscal year in the series	10.8 Employees (FTE) 2023: 10.8 ▲ 4.7 vs 2022 (6.1) Unchanged	15.1 Employees (FTE) 2024: 15.1 ▲ 4.3 vs 2023 (10.8) Unchanged	17.2 Employees (FTE) 2025: 17.2 ▲ 2.1 vs 2024 (15.1) Unchanged	▲ 2.1

Key figures of Protealis, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Protealis?

What happened at Protealis in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 DE LIER stepped down as director. NBB
2029 KORYS MANAGEMENT stepped down as director. NBB
2029 Hartmut VAN LENGERICH stepped down as director. NBB
2028 Tom VIAENE stepped down as director. NBB
2027 Willem BROEKAERT stepped down as director. NBB
2027 Innovation Industries Fund II Coöperatief U.A. stepped down as director. NBB
2027 Patrik HAESEN stepped down as director. NBB
2027 AMPHIBEAN BV stepped down as director. NBB

In short

From € 3.9 million loss in 2022 to € 5 million loss in 2025.

On average € 62,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

V-Bio Fund 2 11.9%

Agri Investment Fund 11.9%

KORYS INVESTMENTS 11.5%

AMPHIBEAN 0.2%

The stake of V-Bio Fund 2, Agri Investment Fund, KORYS INVESTMENTS, AMPHIBEAN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Protealis

The shares are held by V-Bio Fund 2 (11.9%), Agri Investment Fund (11.9%), KORYS INVESTMENTS (11.5%) and AMPHIBEAN (0.2%).

Directors

According to the 2025 annual accounts

DE LIER

Director · represented by François VAN LIERDE

Also active at: ACKERMANS & VAN HAAREN, APIX Biosciences

since 2024 · until 2030

Tom VIAENE

Director

since 2026 · until 2028

Willem BROEKAERT

Director

since 2021 · until 2027

KORYS MANAGEMENT

Director · represented by Vincent DE SMET

Also active at: Colruyt Group, GINSTBRONNEN, reMYND, D-DRINKS GROUP, FLUVES, SOFINDEV IV, URBANTZ, Pantarein Water +19 more

since 2024 · until 2029

Johan CARDOEN

Director

since 2022 · until 2025

Hartmut VAN LENGERICH

Director

since 2024 · until 2029

Innovation Industries Fund II Coöperatief U.A.

Director · represented by Douwe GREEBE CAAJ

since 2021 · until 2027

Patrik HAESEN

Director

since 2021 · until 2027

AMPHIBEAN BV

Director · represented by Benjamin Laga

since 2021 · until 2027

David Buckeridge Investigations Limited

Director · represented by David Buckeridge

since 2021 · until 2027

Shareholders

11.9%

11.9%

11.5%

0.2%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Technologiepark-Zwijnaarde 94

9052 Gent

2.325.710.701

Legen Heirweg 20 box D

9890 Gavere

Active since 10 December 2021

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.

All companies at this address →

ILiAD Biotechnologies

€ 1.4 million gross margin · 2025

Zomagen Biosciences Belgium

€ 1.2 million gross margin · 2025

AnimAb

€ 28,596 gross margin · 2025

ExeVir Bio

€ -1.2 million gross margin · 2025

YAKULT HONSHA EUROPEAN RESEARCH CENTER FOR MICROBIOLOGY

+1 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0765.251.410

VAT number

BE 0765.251.410

Registered office

Technologiepark-Zwijnaarde 94, 9052 Gent

Names & denominations

Protealis

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

16 March 2021

Peppol

Active · Active since 30 Apr 2021

Activities · NACE

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

Protealis

Warning lights

Financials

What happened to Protealis?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions